Versant Vantage II, L.P.
Insider CIK 1832235 · TPST 10% owner · TSBX 10% owner · LYCA 10% owner · GRPH 10% owner · IPSC 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LYCA Lycia Therapeutics, Inc. | C Conversion deriv | 2026-10-26 | 2026-10-28 | 6,284,597 | — | — | 0 | SEC↗ |
| LYCA Lycia Therapeutics, Inc. | C Conversion deriv | 2026-10-26 | 2026-10-28 | 25,390,410 | — | — | 0 | SEC↗ |
| LYCA Lycia Therapeutics, Inc. | C Conversion | 2026-10-26 | 2026-10-28 | 1,393,882 | — | — | 1,393,882 | SEC↗ |
| LYCA Lycia Therapeutics, Inc. | C Conversion | 2026-10-26 | 2026-10-28 | 5,631,425 | — | — | 5,631,425 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-30 | 2025-10-02 | 123 | $47.01 | $5.8K | 764,127 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-30 | 2025-10-02 | 177 | $47.01 | $8.3K | 1,050,599 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-30 | 2025-10-02 | 57,502 | $46.41 | $2.67M | 764,250 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-30 | 2025-10-02 | 83,066 | $46.41 | $3.86M | 1,050,776 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-30 | 2025-10-02 | 49,701 | $45.35 | $2.25M | 1,133,842 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-30 | 2025-10-02 | 34,405 | $45.35 | $1.56M | 821,752 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-18 | 2025-09-22 | 40,907 | $43.00 | $1.76M | 1,183,811 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-18 | 2025-09-22 | 268 | $43.30 | $11.6K | 1,183,543 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-18 | 2025-09-22 | 20,148 | $43.00 | $866.4K | 856,289 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-18 | 2025-09-22 | 132 | $43.30 | $5.7K | 856,157 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-18 | 2025-09-22 | 24,370 | $41.59 | $1.01M | 876,437 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-09-18 | 2025-09-22 | 49,479 | $41.59 | $2.06M | 1,224,718 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-26 | 2025-08-26 | 21,661 | $38.97 | $844.1K | 902,514 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-26 | 2025-08-26 | 3,465 | $39.50 | $136.9K | 1,274,197 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-26 | 2025-08-26 | 1,707 | $39.50 | $67.4K | 900,807 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-26 | 2025-08-26 | 43,978 | $38.97 | $1.71M | 1,277,662 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-25 | 2025-08-26 | 2,149 | $39.92 | $85.8K | 1,321,640 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-25 | 2025-08-26 | 24,760 | $39.53 | $978.8K | 925,233 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-25 | 2025-08-26 | 50,270 | $39.53 | $1.99M | 1,323,789 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-25 | 2025-08-26 | 1,058 | $39.92 | $42.2K | 924,175 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-22 | 2025-08-26 | 10,076 | $40.03 | $403.3K | 952,802 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-22 | 2025-08-26 | 2,809 | $40.59 | $114.0K | 949,993 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-22 | 2025-08-26 | 5,668 | $40.59 | $230.1K | 1,374,059 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-22 | 2025-08-26 | 20,493 | $40.03 | $820.3K | 1,379,727 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-18 | 2025-08-19 | 30,628 | $38.56 | $1.18M | 1,400,220 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-18 | 2025-08-19 | 15,085 | $38.56 | $581.7K | 962,878 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-15 | 2025-08-19 | 145,051 | $39.50 | $5.73M | 1,430,848 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-08-15 | 2025-08-19 | 69,949 | $39.50 | $2.76M | 977,963 | SEC↗ |
| TSBX Turnstone Biologics Corp. | U Tender | 2025-08-08 | 2025-08-12 | 2,726,322 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | U Tender | 2025-08-08 | 2025-08-12 | 207,486 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | U Tender | 2025-08-08 | 2025-08-12 | 90,888 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | U Tender | 2025-08-08 | 2025-08-12 | 274,990 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | U Tender | 2025-08-08 | 2025-08-12 | 82,006 | — | $0 | 0 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-07-10 | 2025-07-14 | 191,376 | $34.00 | $6.51M | 1,575,899 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-06-27 | 2025-07-01 | 200,000 | $30.47 | $6.09M | 1,767,275 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-06-20 | 2025-06-20 | 133,924 | $30.25 | $4.05M | 1,967,275 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-06-20 | 2025-06-20 | 100,877 | $30.35 | $3.06M | 1,047,912 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-06-18 | 2025-06-20 | 100,000 | $29.95 | $3.00M | 1,148,789 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2025-06-10 | 2025-06-12 | 350,000 | $29.00 | $10.15M | 1,248,789 | SEC↗ |
| TPST Tempest Therapeutics, Inc. | S Sale | 2024-08-12 | 2024-08-12 | 387,999 | $1.10 | $426.8K | 209,941 | SEC↗ |
| TPST Tempest Therapeutics, Inc. | S Sale | 2024-08-08 | 2024-08-12 | 400,000 | $1.35 | $540.0K | 597,940 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | J Other | 2024-03-21 | 2024-03-25 | 598,203 | — | $0 | 842,162 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 7,650,043 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 106,208 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 268,711 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 582,206 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 255,081 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 230,117 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 1,119,729 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 85,217 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 37,283 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 33,682 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 2,196,402 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 3,530,789 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 237,575 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 263,349 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 117,730 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 7,897,999 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 601,077 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion | 2023-07-25 | 2023-07-27 | 2,528,864 | — | $0 | 2,528,864 | SEC↗ |
| TSBX Turnstone Biologics Corp. | P Buy | 2023-07-25 | 2023-07-27 | 5,939 | $12.00 | $71.3K | 82,006 | SEC↗ |
| TSBX Turnstone Biologics Corp. | P Buy | 2023-07-25 | 2023-07-27 | 6,575 | $12.00 | $78.9K | 90,888 | SEC↗ |
| TSBX Turnstone Biologics Corp. | P Buy | 2023-07-25 | 2023-07-27 | 15,028 | $12.00 | $180.3K | 207,486 | SEC↗ |
| TSBX Turnstone Biologics Corp. | P Buy | 2023-07-25 | 2023-07-27 | 197,458 | $12.00 | $2.37M | 2,726,322 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion | 2023-07-25 | 2023-07-27 | 274,990 | — | $0 | 274,990 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion | 2023-07-25 | 2023-07-27 | 76,067 | — | $0 | 76,067 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion | 2023-07-25 | 2023-07-27 | 84,313 | — | $0 | 84,313 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion | 2023-07-25 | 2023-07-27 | 192,458 | — | $0 | 192,458 | SEC↗ |
| IPSC Century Therapeutics, Inc. | S Sale | 2022-08-09 | 2022-08-11 | 550,000 | $13.03 | $7.17M | 11,816,814 | SEC↗ |
| IPSC Century Therapeutics, Inc. | J Other | 2022-08-09 | 2022-08-11 | 364,800 | — | $0 | 11,452,014 | SEC↗ |
| IPSC Century Therapeutics, Inc. | J Other | 2022-01-31 | 2022-02-02 | 178,996 | — | $0 | 12,366,814 | SEC↗ |
| IPSC Century Therapeutics, Inc. | J Other | 2021-12-23 | 2021-12-28 | 371,004 | — | $0 | 12,545,810 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 3,715,415 | — | $0 | 0 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 30,019,945 | — | $0 | 0 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 12,343,727 | — | $0 | 14,708,398 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 1,527,719 | — | $0 | 1,527,719 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-06-29 | 2021-07-01 | 180,000 | $17.00 | $3.06M | 1,707,719 | SEC↗ |
| IPSC Century Therapeutics, Inc. | C Conversion deriv | 2021-06-22 | 2021-06-23 | 25,000,000 | — | $0 | 0 | SEC↗ |
| IPSC Century Therapeutics, Inc. | C Conversion deriv | 2021-06-22 | 2021-06-23 | 1,545,125 | — | $0 | 0 | SEC↗ |
| IPSC Century Therapeutics, Inc. | P Buy | 2021-06-22 | 2021-06-23 | 100,000 | $20.00 | $2.00M | 714,095 | SEC↗ |
| IPSC Century Therapeutics, Inc. | C Conversion | 2021-06-22 | 2021-06-23 | 614,095 | — | $0 | 614,095 | SEC↗ |
| IPSC Century Therapeutics, Inc. | C Conversion | 2021-06-22 | 2021-06-23 | 9,936,011 | — | $0 | 12,916,814 | SEC↗ |